Whitepaper: Improving the predictive power of GPCR assays
How much of your compound’s activity are your assays really detecting? Understanding how receptor density impacts pharmacological responses is critical for accurately characterising compound activity & identifying candidates with the highest likelihood of therapeutic success.
Explore this whitepaper by GPCR expert Terry Kenakin, PhD, and EurofinsDiscoverX to discover how tuning receptor density and system sensitivity can reveal hidden efficacies, improve agonist and antagonist characterisation, and deliver more predictive pharmacology.
Key learnings:
• Quantify agonist affinity and efficacy with inducible cell lines usage.
• Characterise antagonists and their hidden efficacies.
• Reveal candidate profiles including allosteric molecules likely to translate into in vivo therapeutic success.
